Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized

Key Record Dates Identifier: NCT05067283
Brief Title: A Study of MK-1084 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Advanced Solid Tumors (MK-1084-001)

First Submitted : October 1, 2021
First Submitted that Met QC Criteria : October 1, 2021
First Posted : October 5, 2021

Last Update Submitted that Met QC Criteria : June 6, 2023
Last Update Posted : June 7, 2023